BeyondSpring (NASDAQ:BYSI) Share Price Crosses Above Fifty Day Moving Average – What’s Next?

BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report)’s share price passed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $0.66 and traded as high as $0.8970. BeyondSpring shares last traded at $0.8059, with a volume of 1,467,567 shares.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised BeyondSpring from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, October 8th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

Read Our Latest Report on BYSI

BeyondSpring Stock Performance

The stock has a market capitalization of $33.14 million, a P/E ratio of -6.72 and a beta of -0.21. The company’s 50-day moving average price is $0.66 and its 200 day moving average price is $1.27.

BeyondSpring (NASDAQ:BYSI – Get Free Report) last issued its earnings results on Friday, August 14th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.54) by $0.52.

About BeyondSpring

(Get Free Report)

BeyondSpring Inc (NASDAQ: BYSI) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer and other serious diseases. The company’s lead product candidate is plinabulin, a small-molecule agent designed to provide both anticancer and immune-modulating effects.

Plinabulin has been investigated as a treatment to prevent chemotherapy-induced neutropenia, a potentially serious reduction in infection-fighting white blood cells that can occur during cancer treatment.

Read More

Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.